{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:40:44Z","timestamp":1789656044762,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ecl.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T15:21:19Z","timestamp":1678288879000},"page":"405-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathobiology of Metabolic-Associated Fatty Liver Disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Sherouk","family":"Fouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Sadiq","family":"Jeeyavudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-5255","authenticated-orcid":false,"given":"Joseph M.","family":"Pappachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataraman","family":"Jayanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ecl.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"10.1016\/j.ecl.2023.01.001_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"39","key":"10.1016\/j.ecl.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"e0173499","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ecl.2023.01.001_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-14-9","article-title":"The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies","volume":"14","author":"van Vliet-Ostaptchouk","year":"2014","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4103\/jod.jod_17_21","article-title":"Clusters and components of metabolic syndrome (MeS) as a predictor for fatty liver: A cross-sectional study","volume":"12","author":"Bhargav","year":"2021","journal-title":"Journal of Diabetology"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and Meta-Analysis","volume":"4","author":"Young","year":"2020","journal-title":"Hepatology communications"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib11","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.32047","article-title":"Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD","volume":"74","author":"Vilarinho","year":"2021","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease","volume":"16","author":"Kim","year":"2022","journal-title":"Gut and liver"},{"issue":"8","key":"10.1016\/j.ecl.2023.01.001_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/17474124.2020.1780915","article-title":"Genetics and epigenetics purpose in nonalcoholic fatty liver disease","volume":"14","author":"Botello-Manilla","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.001_bib15","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2007-2524","article-title":"Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men","volume":"93","author":"van der Meer","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"Journal of hepatology"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.001_bib17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.ecl.2023.01.001_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221122426","article-title":"Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Ma","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"e011939","DOI":"10.1136\/bmjopen-2016-011939","article-title":"Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study","volume":"6","author":"Wei","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ecl.2023.01.001_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ecl.2023.01.001_bib21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3390\/cells9122701","article-title":"Diet rich in simple sugars promotes pro-inflammatory response via gut microbiota alteration and TLR4 signaling","volume":"9","author":"Fajstova","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ecl.2023.01.001_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metabol"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-013-2157-6","article-title":"Pediatric non-alcoholic fatty liver disease: an increasing public health issue","volume":"173","author":"Berardis","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011\u20132012","volume":"50","author":"Nishioji","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"issue":"10","key":"10.1016\/j.ecl.2023.01.001_bib26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ecl.2023.01.001_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"22","key":"10.1016\/j.ecl.2023.01.001_bib28","first-page":"00669","article-title":"Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs. Non-Lean NAFLD-A Systematic Review and Meta-Analysis","volume":"S1542-3565","author":"Tang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.001_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"Journal of hepatology"},{"issue":"16","key":"10.1016\/j.ecl.2023.01.001_bib30","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","article-title":"Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis","volume":"67","author":"Zeb","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ecl.2023.01.001_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib33","doi-asserted-by":"crossref","first-page":"e57183","DOI":"10.1371\/journal.pone.0057183","article-title":"Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes","volume":"8","author":"Targher","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib34","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1038\/s41598-021-95581-8","article-title":"Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease","volume":"11","author":"Arai","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.diabres.2011.06.013","article-title":"Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS)","volume":"93","author":"Kim","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.ecl.2023.01.001_bib36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.001_bib37","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.32578","article-title":"Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study","volume":"76","author":"Sinn","year":"2022","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.ecl.2023.01.001_bib38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3748\/wjg.v26.i20.2669","article-title":"Association between non-alcoholic fatty liver disease and obstructive sleep apnea","volume":"26","author":"Umbro","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib39","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/s41598-021-92703-0","article-title":"Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea","volume":"11","author":"Chung","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ecl.2023.01.001_bib40","doi-asserted-by":"crossref","first-page":"650758","DOI":"10.3389\/fphys.2021.650758","article-title":"Insulin Resistance and Type 2 Diabetes in Asymptomatic Obstructive Sleep Apnea: Results of the PROOF Cohort Study After 7 Years of Follow-Up","volume":"12","author":"Vacelet","year":"2021","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.001_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes","volume":"73","author":"Sarkar","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/liv.12902","article-title":"Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease","volume":"36","author":"Hagstr\u00f6m","year":"2016","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.ecl.2023.01.001_bib43","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.3390\/ijms20112841","article-title":"NAFLD in some common endocrine diseases: prevalence, pathophysiology, and principles of diagnosis and management","volume":"20","author":"Lonardo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12978-018-0519-2","article-title":"A\u00a0potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nu10040474","article-title":"MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches","volume":"10","author":"De Lorenzo","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.001_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2023.01.001_bib48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","article-title":"Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study","volume":"73","author":"Kalinchenko","year":"2010","journal-title":"Clinical endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.001_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/en.2013-1648","article-title":"Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats","volume":"155","author":"Nikolaenko","year":"2014","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.ecl.2023.01.001_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:38Z","timestamp":1760176058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852923000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0889852923000014"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2023.01.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathobiology of Metabolic-Associated Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}